FXAIX
Price
$187.98
Change
-$9.55 (-4.83%)
Updated
Apr 3 closing price
Net Assets
597.55B
MLVPX
Price
$18.63
Change
-$0.43 (-2.26%)
Updated
Apr 3 closing price
Net Assets
356.86M
Ad is loading...

FXAIX vs MLVPX

Header iconFXAIX vs MLVPX Comparison
Open Charts FXAIX vs MLVPXBanner chart's image
Fidelity 500 Index
Price$187.98
Change-$9.55 (-4.83%)
VolumeN/A
Net Assets597.55B
MFS Low Volatility Equity R3
Price$18.63
Change-$0.43 (-2.26%)
VolumeN/A
Net Assets356.86M
FXAIX vs MLVPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. MLVPX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Hold and MLVPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. MLVPX (357M). FXAIX pays higher dividends than MLVPX: FXAIX (1.30) vs MLVPX (0.91). FXAIX was incepted earlier than MLVPX: FXAIX (14 years) vs MLVPX (11 years). MLVPX (0.94) is less costly to investors than FXAIX (0.01). MLVPX is a more actively managed with annual turnover of: 25.00 vs. FXAIX (2.00). FXAIX (0) and MLVPX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 10.29 vs. MLVPX (-3.27). FXAIX return over 5 years is better than : 146.07 vs. MLVPX (49.38).
FXAIXMLVPXFXAIX / MLVPX
Total Expense Ratio0.010.892%
Annual Report Gross Expense Ratio0.010.942%
Fund Existence14 years11 years-
Gain YTD-3.2622.427-134%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets598B357M167,507%
Annual Yield % from dividends1.300.91143%
Returns for 1 year10.29-3.27-315%
Returns for 3 years29.57-8.60-344%
Returns for 5 years146.0749.38296%
Returns for 10 years197.2482.46239%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRSLX23.77N/A
N/A
Nuveen Small/Mid Cap Growth Opp A
LMNOX39.31N/A
N/A
Patient Opportunity I
MNBIX19.37N/A
N/A
Manning & Napier Pro-Blend Extnd Term I
ALCBX11.95N/A
N/A
ALPS/Smith Balanced Opportunity C
POLIX44.45N/A
N/A
Polen Growth Institutional